Report Store Get Proposal

Home Blog Ophthalmology 2

Ophthalmology

pharma-news-for-bms-astrazeneca-astellas-akebia

Notizia - Recent Pharma, Healthcare and Biotech Happenings

AstraZeneca’s Voydeya FDA Approval; Akebia’s Vafseo FDA Approval; Bristol Myers Squibb’s Phase III YELLOWSTONE Trial Update; Astellas’ IZERVAY FDA Approval; AstraZeneca’s Truqap and Faslodex MHLW Approval

Voydeya Receives FDA Approval as Supplemental Treatment with Ravulizumab or Eculizumab for Managing Extravascular Hemolysis in Adult Patients with PNH Voydeya (danicopan) has received approval in the United States for use alongside ravulizumab or eculizumab in treating extravascular hemolysis (EVH) in adults diagnosed with paroxysmal nocturnal hemoglobinuria (PNH). This innovative oral Factor D inhibitor, Voydeya, is the first of its kind and is designed to complement the standard treatments Ultomiris (ravulizumab) or Soliris (eculizumab). Its purpose is to cater to the needs of the roughly 10-20% of PNH patients who undergo clinically significant EVH despite being...

Explore More...

MedTech News for Integra, B. Braun, Medtronic, Perfuze

Integra to Buy J&J’s Acclarent; B. Braun Launches the CARESITE Micro Luer Access Devic; FDA Approves Medtronic’s Novel PulseSelect Pulsed Field Ablation System; FDA Clearances to Perfuze’s Novel Neurovascular Aspiration and Access Catheters for Stroke Treatment; ShiraTronics Successfully Implants First Migraine System; Sight Sciences Announced the Six-Month Results For Heat Therapy Device

Artificial Tears Market Analysis

Exploring the Growing Demand and Evolving Market Dynamics of Artificial Tears

MedTech News for Laminar, BD, Vivos, Zilia, Penumbra

Johnson & Johnson Medtech Acquired Laminar; BD Launched Advanced Vascular Access Ultrasound System; FDA Cleared Oral Device for Severe Sleep Apnea; FDA Clearanced the Zilia OcularTM FC Retinal Camera; First Patient Enrolled in Penumbra Study of Computer-assisted Vacuum Thrombectomy; US FDA Granted the BiVACOR Total Artificial Heart IDE Approval for First-in-Human Early Feasibility Study

vabysmo-for-retinal-vein-occlusion-treatment

Roche’s Vabysmo Third US Approval Spiced Up the Battle With Regeneron and Bayer’s Eylea

Pharma News for GSK, Roche, Eli Lilly, Coherus

Phase III RUBY Trial of Jemperli Plus Chemotherapy Updates; FDA Approves Roche’s Vabysmo for RVO; FDA Grants Priority Review to Tovorafenib Low-Grade Glioma; FDA Approves Lilly’s Omvoh; FDA Approves Toripalimab for Nasopharyngeal Carcinoma; FDA Fast Track Designation to ONCT-534 R/R mCRPC

MedTech News for Mindray, DuPont, Praxis

Mindray Collaborated with Edwards Lifesciences; DuPont’s Low-Cyclics Silicone Soft Skin Adhesive; GE HealthCare’s Allia IGS Pulse; Praxis Medical’s EndoCore EBUS-TBNA Biopsy Device; Visioneering’s PROTECT Clinical Trial; SynerFuse’s e-TLIF procedure

top-rare-eye-diseases

The Hidden World of Vision: Exploring the Top 5 Rare Eye Diseases

Contact Lenses Market Trends

Contact Lenses: A Comprehensive Guide to Vision Correction and Beyond

Pharma News for Gilead, Incannex, Avidity

Eylea HD Injection 8 Mg Approved By FDA; Veopoz Receives FDA Approval for CHAPLE Disease Treatment; FDA Places Second Partial Clinical Hold on AML Enrollment for Magrolimab Trials; FDA Approval to Incannex’s Sleep Apnoea Clinical Trial; FDA Orphan Drug Designation to Avidity’s AOC 1044; Orphan Drug Designation to CanariaBio’s MAb-AR20.5

izervay-for-geographic-atrophy-treatment

Entry of Izervay: First Geographic Atrophy Treatment to Slow Progression

Pharma News for Biogen, Astellas, Ascentage

FDA Approves ZURZUVAE for Postpartum Depression; Astellas Drug Acquired in $5.9B Deal Wins FDA Approval; FDA Clearance to Phase III Study of Lisaftoclax; FDA Issues CRL to BLA Resubmission for Remestemcel-L; Bavarian Nordic Updated on its Chikungunya Virus Vaccine; FDA Orphan Drug Designation to ABM-1310

bullous-keratopathy-treatment

Will Cell Therapy Bridge the Gap in Bullous Keratopathy Treatment Space?

Artificial Organs Market

Innovative Solutions, Lifesaving Possibilities: Evaluating the Artificial Organs Market Dynamics

MedTech News for Enovis, Dexcom, Abbott, Elios

Enovis Acquires Novastep; Rockwell Medical Announced Collaboration with B. Braun; Dexcom G7 Received Health Canada Approval for Next-Generation CGM; Abbott’s World’s First Dual Chamber Leadless Pacemaker; Elios Vision’s Pivotal Trial of ELIOS; Synergy Spine’s Synergy Disc 2-Level IDE Trial

uveitis-treatment

New Frontiers in Uveitis Treatment: Updates and Innovations

Pharma News for GSK, Roche, Avita, Ipsen

FDA Extended the Review Period for Momelotinib; FDA Approves Roche’s Columvi; Avita Medical Obtains FDA Approval of RECELL; FDA Approves Odevixibat for ALGS; TME Pharma Receives IND Approval for NOX-A12; Aldeyra’s Phase 3 INVIGORATE‑2 Trial of Reproxalap

Subscribe to our Updates

DelveInsight is dedicated to safeguarding your data. We ensure that your information is handled in compliance with relevant data privacy legislation, our internal guidelines, and our privacy policy.

Receive recent Healthcare updates directly in your inbox.

Daily

Weekly

Monthly